1. Overcome Cancer Cell Drug Resistance Using Natural Products.
   Pu Wang et al, 2015, Evid Based Complement Alternat Med CrossRef
2. null
   Camile C. Fontelles et al, 2017 CrossRef
3. Enzyme targeting strategies for prevention and treatment of cancer: Implications for cancer therapy.
   Mohammad Hassan Baig et al, 2019, Semin Cancer Biol CrossRef
4. Involvement of glutathione and glutathione metabolizing enzymes in human colorectal cancer cell lines and tissues
   AREUM DASEUL KIM et al, 2015 CrossRef
5. Selenium and Chronic Diseases: A Nutritional Genomics Perspective
   Catherine Méplan, 2015, Nutrients CrossRef
6. Gold(III) bis(thiosemicarbazonate) compounds in breast cancer cells: Cytotoxicity and thioredoxin reductase targeting
   Vanessa Rodríguez-Fanjul et al, 2018, European Journal of Medicinal Chemistry CrossRef
7. null
   Amy L. Stockert et al, 2018 CrossRef
8. The synthetic histone-binding regulator protein PcTF activates interferon genes in breast cancer cells
   Kimberly C. Olney et al, 2018, BMC Syst Biol CrossRef
9. Oxidant stress induction and signalling in xenografted (human breast cancer-tissues) plus estradiol treated or N-ethyl-N-nitrosourea treated female rats via altered estrogen sulfotransferase (rSULT1E1) expressions and SOD1/catalase regulations
   Aarifa Nazmeen et al, 2018, Mol Biol Rep CrossRef
10. Modulating ROS to overcome multidrug resistance in cancer
    Qingbin Cui et al, 2018, Drug Resistance Updates CrossRef
11. Thymosin alpha‐1; a natural peptide inhibits cellular proliferation, cell migration, the level of reactive oxygen species and promotes the activity of antioxidant enzymes in human lung epithelial adenocarcinoma cell line (A549)
    Jasmin Kharazmi‐Khorassani et al, 2019, Environmental Toxicology CrossRef
12. SEPP1 Influences Breast Cancer Risk among Women with Greater Native American Ancestry: The Breast Cancer Health Disparities Study
    Andrew J. Pellatt et al, 2013, PLoS ONE CrossRef
13. null
    Gayathri R. Devi et al, 2014 CrossRef
14. Dietary Vitamin D3 Restriction Exacerbates Disease Pathophysiology in the Spinal Cord of the G93A Mouse Model of Amyotrophic Lateral Sclerosis
    Elnaz Moghimi et al, 2015, PLoS ONE CrossRef
15. Supplementation with Selenium yeast on the prooxidant–antioxidant activities and anti-tumor effects in breast tumor xenograft-bearing mice
    Chih-Hung Guo et al, 2015, The Journal of Nutritional Biochemistry CrossRef
16. null
    L. P. Madhubhani P. Hemachandra et al, 2016 CrossRef
17. Regulation of multidrug resistance by microRNAs in anti-cancer therapy
    Xin An et al, 2017, Acta Pharmaceutica Sinica B CrossRef
18. Glutathione peroxidase-1 regulates adhesion and metastasis of triple-negative breast cancer cells via FAK signaling
    Eunkyung Lee et al, 2019, Redox Biology CrossRef
19. Harnessing altered oxidative metabolism in cancer by augmented prooxidant therapy
    Malgorzata Firczuk et al, 2019, Cancer Letters CrossRef
20. mTOR-Mediated Antioxidant Activation in Solid Tumor Radioresistance
    Yunseo Woo et al, 2019, Journal of Oncology CrossRef
21. Synthesis of micellar-like terpolymer nanoparticles with reductively-cleavable cross-links and evaluation of efficacy in 2D and 3D models of triple negative breast cancer
    Patrícia F. Monteiro et al, 2020, Journal of Controlled Release CrossRef
22. Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers
    Barak Rotblat et al, 2013, Oncotarget CrossRef
23. Effect of redox‐responsive DTSSP crosslinking on poly( l ‐lysine)‐grafted‐poly(ethylene glycol) nanoparticles for delivery of proteins
    Joshua Seaberg et al, 2020, Biotechnology and Bioengineering CrossRef
24. Rlip Depletion Suppresses Growth of Breast Cancer
    Chhanda Bose et al, 2020, Cancers CrossRef
25. The Effect of Glutathione Peroxidase-1 Knockout on Anticancer Drug Sensitivities and Reactive Oxygen Species in Haploid HAP-1 Cells
    Steven Behnisch-Cornwell et al, 2020, Antioxidants CrossRef
26. Special Dietary Supplements
    Deran DALBUDAK SANSAR et al, 2021 CrossRef
27. null
    Amy L. Stockert et al, 2021 CrossRef
28. The correlation of antioxidant levels of breast cancer
    Mohammed Yaseen Khalaf et al, 2021 CrossRef
29. Targeting Drug Chemo-Resistance in Cancer Using Natural Products.
    Wamidh H Talib et al, 2021, Biomedicines CrossRef
30. Latest developments in metal complexes as anticancer agents
    Renata Paprocka et al, 2022, Coordination Chemistry Reviews CrossRef
31. null
    Bee Ling Tan et al, 2021 CrossRef
32. Tissue levels of oxidative stress markers and antioxidants in colorectal cancer patients
    Abdullah Burwaiss et al, 2021, MGC CrossRef
33. An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer
    Susan Costantini et al, 2022, Cancers CrossRef
34. Genetic variation at the catalytic subunit of glutamate cysteine ligase contributes to the susceptibility to sporadic colorectal cancer: a pilot study
    Marina A. Bykanova et al, 2022, Mol Biol Rep CrossRef
35. The role of glutathione peroxidase-1 in health and disease
    Diane E. Handy et al, 2022, Free Radical Biology and Medicine CrossRef
36. High-Dose Vitamin C for Cancer Therapy
    Ali Mussa et al, 2022, Pharmaceuticals CrossRef
37. MYH9 Facilitates Cell Invasion and Radioresistance in Head and Neck Cancer via Modulation of Cellular ROS Levels by Activating the MAPK-Nrf2-GCLC Pathway
    Guo-Rung You et al, 2022, Cells CrossRef
38. Why Do Dietary Flavonoids Have a Promising Effect as Enhancers of Anthracyclines? Hydroxyl Substituents, Bioavailability and Biological Activity
    Aleksandra Golonko et al, 2022, IJMS CrossRef
39. Aptamers against cancer drug resistance: Small fighters switching tactics in the face of defeat
    Mehdi Sanati et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
40. Redox and metabolic reprogramming in breast cancer and cancer‐associated adipose tissue
    Tamara Zakic et al, 2023, FEBS Letters CrossRef
41. Mesenchymal–epithelial transition and AXL inhibitor TP-0903 sensitise triple-negative breast cancer cells to the antimalarial compound, artesunate
    Mirko Terragno et al, 2024, Sci Rep CrossRef
42. Organic Sulfur Derivatives and Their Metal Complexes as Promising Pharmacologically Active Compounds
    V. P. Osipova et al, 2023, Russ J Coord Chem CrossRef
43. Usnic acid alleviates inflammatory responses and induces apoptotic signaling through inhibiting NF‐ĸB expressions in human oral carcinoma cells
    Theerthu Azhamuthu et al, 2024, Cell Biochemistry & Function CrossRef
44. Molecular mechanisms of tumor drug resistance
    E.V. Okladnikova et al, 2023, Mol Med Rus CrossRef
45. USP35 promotes the growth of ER positive breast cancer by inhibiting ferroptosis via BRD4-SLC7A11 axis
    Jiawei Cao et al, 2025, Commun Biol CrossRef
46. Targeting estrogen-regulated system xc− promotes ferroptosis and endocrine sensitivity of ER+ breast cancer
    Jiawei Cao et al, 2025, Cell Death Dis CrossRef